CAP: Committee of Advertising Practice

The Committee of Advertising Practice is responsible for updating and creating the rules upheld by its sister organisation, the Advertising Standards Authority.

The Committee of Advertising Practice design codes and principles for marketers, promoters and advertisers to follow when publishing in the UK. These official principles are created to ensure there is a high standard of advertising that is suitable and safe for the British audiences. 


What are the advertising standards surrounding medical cannabis in the UK?


Medical cannabis is a highly regulated industry in the UK. Advertising for medical cannabis products must adhere to strict guidelines. These guidelines include avoiding making any false or unproven claims about the medical benefits of cannabis, ensuring that any scientific studies referenced are accurate and up-to-date, and not targeting minors or those with a history of substance abuse.


Are there any specific regulations for advertising cannabis-based products in the UK?


Yes, there are specific regulations for advertising cannabis-based products in the UK. These include avoiding any association with illegal drug use, ensuring that any health claims are supported by scientific evidence, and not making false or misleading statements about the product. It is also important to note that all advertisements for medical cannabis must be approved by the Medicines and Healthcare products Regulatory Agency (MHRA).

To find out more about the Committee of Advertising Practice, click here.

If you would like to learn more about medical cannabis in the UK, Releaf is here to help.